Champions Oncology
CSBR
CSBR
45 hedge funds and large institutions have $47.2M invested in Champions Oncology in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
53% less capital invested
Capital invested by funds: $100M → $47.2M (-$52.8M)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$961K | |
| 2 | +$542K | |
| 3 | +$506K | |
| 4 |
Bank of New York Mellon
New York
|
+$409K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$405K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$642K | |
| 3 | -$503K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$344K |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$290K |